Everads Therapy vs Impact Biotech
Everads Therapy vs Impact Biotech, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Everads Therapy is on 26/100 and Impact Biotech on 39/100.
Where each one leads
Everads Therapy
- agent readiness: 48/100 against 21/100
- domain rating: 31/100 against 20/100
Impact Biotech
- our overall score: 39/100 against 26/100
- headcount: 42 against 10
- headcount growth: +16.9% against +8.5%
- LinkedIn following: 1,470 against 392
At a glance
| Measure | Everads Therapy | Impact Biotech |
|---|---|---|
| What it is | Developing novel suprachoroidal delivery technology for targeted, rapid, and durable retinal disease treatments. | Develops and launches Padeliporfin VTP therapy for solid tumor treatment. |
| Category | Life Sciences, MedTech, HealthTech, Drug Discovery | Life Sciences, Cancer, Therapeutics, Biotech |
| Sells toBusiness model | B2B | B2B |
| Offering | Hardware | Software |
| Founded | 2017 | 1996 |
| Headquarters | Not published | Tel Aviv, Israel |
| Status | Active | Active |
Size, funding and growth
| Measure | Everads Therapy | Impact Biotech |
|---|---|---|
| Employees | 10 | 42 |
| Headcount growthLast 12 months | +8.5% | +16.9% |
| Total funding | Not published | $2.7M |
| Latest round | Bootstrapped | Grant |
| LinkedIn followers | 392 | 1,470 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Everads Therapy | Impact Biotech |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 26/100 | 39/100 |
| Traction | 10/100 | 49/100 |
| Team | 30/100 | Not published |
| Search visibility | 27/100 | 34/100 |
| Quality | Not published | 45/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (48/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 31/100 | 20/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Everads Therapy | Impact Biotech |
|---|---|---|
| Hosting | Not detected | Self Managed |
| CDN | Cloudflare | Not detected |
| CMS | Wix | WordPress |
| Frameworks | Not detected | Jquery |
| Analytics | Not detected | Google Analytics 4 |
Everads Therapy vs Impact Biotech: common questions
Which is better, Everads Therapy or Impact Biotech?
On our 0-100 score Impact Biotech rates higher (39/100 against 26/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.
How do Everads Therapy and Impact Biotech compare on the numbers?
Everads Therapy leads on agent readiness (48/100 against 21/100), domain rating (31/100 against 20/100). Impact Biotech leads on our overall score (39/100 against 26/100), headcount (42 against 10), headcount growth (+16.9% against +8.5%), LinkedIn following (1,470 against 392).
Read the full Everads Therapy review and pricing or the Impact Biotech review and pricing. You can also browse other Everads Therapy alternatives we track.